Cite
HARVARD Citation
Carulli, M. et al. (2008). Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?. Annals of the rheumatic diseases. 67 (1), pp. 105-109. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carulli, M. et al. (2008). Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?. Annals of the rheumatic diseases. 67 (1), pp. 105-109. [Online].